Sono Tek CorpSOTK

Sono-Tek’s ultrasonic coating systems-ExactaCoat, FlexiCoat, MediCoat and the rest-are the quiet workhorses behind everything from solar cells to medical devices, yet the company’s latest quarter reads like a story of two customers rather than two hundred. The 10-Q for the three months ending 31 May 2026 shows $5.7 million in revenue, but also reveals that 53% of sales came from just two buyers, one of which cut orders in the clean-energy sector from a prior quarter’s $2.16 million to a fraction of that figure. The filing names no names, leaving analysts to wonder whether the drop is cyclical or a sign that Sono-Tek’s diversification push has yet to take root.

On paper, Sono-Tek looks solid: $9 million in cash, $25.9 million in assets, and $741,168 in net profit for the quarter. But the same document flags a $196,453 inventory build-up-cash tied up in nozzles and rigs that may or may not sell this year-and $616,982 sunk into R&D. The company’s DEF 14A highlights a nominating committee chaired by a director whose résumé includes stints as Worldwide Sales and Marketing Manager, a credential that sounds impressive until you ask what it changes about customer concentration.

The 10-Q is a masterclass in transparency followed by a masterclass in opacity: it gives us revenue, net profit, cash, inventory, and R&D spend for the quarter, but it offers no segment split beyond “foreign” versus “domestic,” no clean-energy breakdown beyond the single-line drop to $2.16 million, and no customer names to anchor the story. The balance sheet is healthy, but the income statement is a one-act play starring two customers and a solar-coating outfit whose mood swings matter more than any management desks slide deck.

For context, Sono-Tek’s products page lists ultrasonic systems for R&D through high-volume production, and the services page promises worldwide support for all coating equipment. Those pages explain what the company sells; the filings explain why investors might want to see more than two names in the sales ledger. The DEF 14A and the 10-Q are both available via the company’s proxy and investor pages, and they are the only sources that matter for the numbers and governance details.

The tension isn’t in the technology-ultrasonic nozzles are real, and Sono-Tek’s offerings are visible in product shots and service descriptions-but in the execution risk. A $5.7 million quarter with 53% concentration is not a diversified business; it’s a concentrated bet dressed in lab coats. Until the next 10-Q names the customers and breaks out the clean-energy exposure, the polished platform story remains a brochure waiting for a balance sheet to catch up.